← all drugs
Irinotecan Hydrochloride Injection
being discontinued · Oncology · Snapshot: 2026-10-09
- Manufacturers listed
- Ingenus Pharmaceuticals LLC
- Machine-readable
- JSON for this drug
Presentations (2)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05) | Ingenus Pharmaceuticals LLC | unknown | 02/24/2026 |
| Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02) | Ingenus Pharmaceuticals LLC | unknown | 02/24/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.